Some of the compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Scientific Congress Publications
Supported by Bayer Pharmaceuticals
ESC HF 2025
ESC HF_vericiguat_dosing titration and cox model_15 April 2025.pdf
ePoster_HFA-Congress_2025_ROVER_Adh-Pers_v02 (2).pdf
ePoster_HFA-Congress_2025_ROVER_ACM-HFH_v03 (1).pdf
Poster+Belgrado_Diagnosis+management+HFrEF+patient_v0.4_20250408 (1).pdf
25-04-22_VICTOR Regional BL_POS v2.0.pdf
FINAL_VELOCITY_LBCT_May14.pdf
ESC HF_vericiguat_clinical characteristics and outcomes_v3 (14 Apr).pdf